Characteristics including Ogata score and phenotypic aberrancies may correlate with mutational patterns that are predictive of treatment response in patients with myelodysplastic syndrome. This ...

Investigators sought to show how individual cases could be clarified through the use of flow cytometry analysis. Corresponding author Theresia M. Westers, PhD, of Amsterdam University Medical Centers ...

The myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders with a heterogeneous presentation and clinical course. The majority of patients will succumb to the ...

Myelodysplastic syndromes (MDS) describe cancers resulting from abnormal cells in the bone marrow. The abnormal bone marrow cells generate defective blood cells, which die earlier than normal blood ...

Risk scoring methods continue to evolve with increased understanding of the factors that affect specific patient group outcomes in MDS. Diagnosis of MDS is currently based on morphology, but can be ...

Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS. Multiparameter flow cytometry in the evaluation of ...

Efficacy and tolerability of pregabalin in the management of pain associated with administration of high-dose imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic phase ...

The UAB Flow Cytometry Lab is home to a staff of medical laboratory professionals who perform complex testing using state-of-the-art flow cytometry equipment. This testing, through research, education ...

BM samples obtained from 82 primary RCC patients (median age: 10.5 years, range: 1.3–17.9), not previously treated with immunosuppressive therapy, were available for analysis by flow cytometry.

Correction to "Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow ...